Related Experiment Videos
Temporal bone neoplasms: a report on 20 surgically treated cases.
L N Sekhar1, S Pomeranz, I P Janecka
1Department of Neurological Surgery, University of Pittsburgh, School of Medicine, Pennsylvania.
Journal of Neurosurgery
|April 1, 1992
Summary
Surgical resection of petrous bone tumors is feasible, even with extensive invasion. Outcomes depend on tumor type, with benign and slow-growing neoplasms showing better prognosis than fast-growing malignancies.
Area of Science:
- Neurosurgery
- Oncology
- Skull Base Surgery
Background:
- Surgical resection of petrous bone neoplasms presents significant challenges due to proximity to critical neurovascular structures.
- Advanced surgical techniques are crucial for managing complex tumors involving the petrous bone, dura, brain, and major vessels.
Observation:
- This study reports on the surgical resection of petrous bone tumors in 20 patients.
- Technical advancements enabled the complete resection of tumors previously deemed inoperable, including those involving the petrous internal carotid artery (ICA), cavernous sinus, and clivus.
- Reconstruction involved the ICA, cranial nerves VII and XI, and the cranial base, often utilizing vascularized flaps.
Findings:
- No intraoperative deaths occurred.
- Temporary morbidity, including wound healing issues and lower cranial nerve palsy, was observed.
- Most patients returned to their preoperative functional status, except for three with fast-growing malignancies.
- Patients with benign or slow-growing tumors had favorable outcomes (7/10 alive and disease-free).
- Patients with fast-growing malignancies had poor outcomes (2/10 alive without disease), correlating with tumor pathology and invasion extent.
Implications:
- Surgical resection is a viable option for petrous bone neoplasms, with outcomes influenced by tumor biology and extent.
- Anatomical classification of tumor spread, alongside pathology, is essential for predicting prognosis.
- Further research into surgical strategies and adjuvant therapies for aggressive petrous bone tumors is warranted.